Africa unveils groundbreaking HIV-prevention injection Story by Mercy Adaje South Africa, Eswatini, and Zambia on Monday began administering a groundbreaking HIV-prevention injection—lenacapavir—in the drug’s first public deployment on the African continent, which carries the world’s heaviest HIV burden. Lenacapavir, taken just twice annually, has demonstrated more than 99.9% effectiveness in reducing HIV transmission, making it comparable to a powerful vaccine. In South Africa, where one in every five adults is living with HIV, the rollout is being overseen by a Wits University research unit under a Unitaid-funded programme. Unitaid confirmed that the first...